{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:06:15Z","timestamp":1787666775391,"version":"build-2736575974"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013494","name":"West Light Foundation of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2021-JCTD-001"],"award-info":[{"award-number":["2021-JCTD-001"]}],"id":[{"id":"10.13039\/501100013494","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009110","name":"Xinjiang Uygur Autonomous Region Natural Science Foundation","doi-asserted-by":"publisher","award":["2022D01A340"],"award-info":[{"award-number":["2022D01A340"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009110","name":"Xinjiang Uygur Autonomous Region Natural Science Foundation","doi-asserted-by":"publisher","award":["2022D01A339"],"award-info":[{"award-number":["2022D01A339"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2023-XBQNXZ009"],"award-info":[{"award-number":["2023-XBQNXZ009"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2021-XBQNXZ-009"],"award-info":[{"award-number":["2021-XBQNXZ-009"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmc.2025.118375","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T06:53:10Z","timestamp":1756882390000},"page":"118375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Aurone and its analogues as targeted drugs for the anticancer treatment"],"prefix":"10.1016","volume":"130","author":[{"given":"Miaomiao","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurshed","family":"Bozorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haji Akber","family":"Aisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118375_bb0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1582-4934.2012.01663.x","article-title":"Apoptosis drives cancer cells proliferate and metastasize","volume":"17","author":"Wang","year":"2013","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.bmc.2025.118375_bb0010","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(13)62224-2","article-title":"Global cancer patterns: causes and prevention","volume":"383","author":"Vineis","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2025.118375_bb0015","unstructured":"World Health Organization, International Agency for Research on Cancer. Global cancer burden growing, amidst mounting need for services (News release No. 290). 2024 Feb 1. https:\/\/www.iarc.who.int\/news-events\/global-cancer-burden-growing-amidst-mounting-need-for-services\/."},{"key":"10.1016\/j.bmc.2025.118375_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","article-title":"Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways","volume":"19","author":"Kraehenbuehl","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bmc.2025.118375_bb0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","article-title":"Cancer treatments: past, present, and future","volume":"286","author":"Sonkin","year":"2024","journal-title":"Cancer Genet"},{"key":"10.1016\/j.bmc.2025.118375_bb0030","first-page":"2","article-title":"Evolutionary dynamics of cancer in response to targeted combination therapy","author":"Bozic","year":"2013","journal-title":"eLife"},{"key":"10.1016\/j.bmc.2025.118375_bb0035","first-page":"31","article-title":"The interplay between gut bacteria and targeted therapies: implications for future cancer treatments","author":"He","year":"2025","journal-title":"Mol Med"},{"key":"10.1016\/j.bmc.2025.118375_bb0040","first-page":"3","article-title":"Small molecule inhibitors targeting the cancers","author":"Liu","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.bmc.2025.118375_bb0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/0118756298277226231128032502","article-title":"Biological activities of Aurones: a brief summary","volume":"22","author":"Zhu","year":"2025","journal-title":"Mini-Rev Org Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0050","first-page":"29","article-title":"Recent advances on synthesis and biological activities of aurones","author":"Sui","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ejmech.2019.01.078","article-title":"Aurone: a biologically attractive scaffold as anticancer agent","volume":"166","author":"Alsayari","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0060","first-page":"27","article-title":"Aurones: a golden resource for active compounds","author":"Mazziotti","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118375_bb0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2174\/1385272827666230407110607","article-title":"A review of the various synthetic approaches to access Aurone derivatives and their biological activities","volume":"27","author":"Lathwal","year":"2023","journal-title":"Curr Org Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0070","first-page":"341","article-title":"Studien uber das Anthochlor","volume":"129","author":"Klein","year":"1920","journal-title":"Sitzb Akad Wiss Wien"},{"key":"10.1016\/j.bmc.2025.118375_bb0075","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/167688a0","article-title":"Benzalcoumaranones","volume":"167","author":"Batesmith","year":"1951","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2025.118375_bb0080","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1021\/ja01244a050","article-title":"Anthochlor pigments IV: the pigments of Coreopsis grandiflora Nutt. I","volume":"65","author":"Geissman","year":"1943","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2025.118375_bb0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.phytochem.2017.06.017","article-title":"Occurrences, biosynthesis and properties of aurones as high-end evolutionary products","volume":"142","author":"Boucherle","year":"2017","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bmc.2025.118375_bb0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fpls.2020.00007","article-title":"The evolution of flavonoid biosynthesis: a bryophyte perspective","volume":"11","author":"Davies","year":"2020","journal-title":"Front Plant Sci"},{"key":"10.1016\/j.bmc.2025.118375_bb0095","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1080\/10942912.2016.1220393","article-title":"Natural polyphenols: an overview","volume":"20","author":"Abbas","year":"2017","journal-title":"Int J Food Prop"},{"key":"10.1016\/j.bmc.2025.118375_bb0100","doi-asserted-by":"crossref","first-page":"12594","DOI":"10.1021\/acs.jmedchem.2c01150","article-title":"Bioactive aurones, indanones, and other hemiindigoid scaffolds: medicinal chemistry and photopharmacology perspectives","volume":"65","author":"Lazinski","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrd4504","article-title":"The history and future of targeting cyclin-dependent kinases in cancer therapy","volume":"14","author":"Asghar","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2025.118375_bb0110","first-page":"12","article-title":"Novel benzylidene benzofuranone analogues as potential anticancer agents: design, synthesis and in vitro evaluation based on CDK2 inhibition assays","author":"Pai","year":"2022","journal-title":"3 Biotech"},{"key":"10.1016\/j.bmc.2025.118375_bb0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4155\/fmc-2017-0147","article-title":"Construction of cytotoxic agents with aurone and furoaurone scaffolds","volume":"10","author":"Hassan","year":"2018","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0120","first-page":"9","article-title":"Design, synthesis and anticancer evaluation of polymethoxy aurones as potential cell cycle inhibitors","author":"Wu","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bmc.2025.118375_bb0125","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.1080\/10406638.2022.2127801","article-title":"Regio- and stereoselective synthesis of dispiropyrrolidineoxindole derivatives by using classical and microwave conditions, and molecular docking studies of them as potential cyclin dependent kinases (CDK5) inhibitors","volume":"43","author":"Moghaddam","year":"2022","journal-title":"Polycycl Aromat Compd"},{"key":"10.1016\/j.bmc.2025.118375_bb0130","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/jhet.4595","article-title":"Ultrasound-promoted 1,3-dipolar cycloaddition of azomethine yields for synthesis of dispiropyrrolidineoxindole derivatives in hexyltriphenylphosphonium bromide as an ionic liquid, and the evaluation of their anti-cancer activity","volume":"60","author":"Moghaddam","year":"2022","journal-title":"J Heterocyclic Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejmech.2019.03.050","article-title":"PIM kinase inhibitors: structural and pharmacological perspectives","volume":"172","author":"Asati","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0140","first-page":"14","article-title":"Structure-based virtual screening and de novo design of PIM1 inhibitors with anticancer activity from natural products","author":"Park","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmc.2025.118375_bb0145","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1007\/s00018-009-9154-y","article-title":"Protein kinase CK2 in health and disease","volume":"66","author":"Trembley","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bmc.2025.118375_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104062","article-title":"Flavone inspired discovery of Benzylidenebenzofuran-3(2H)-ones (Aurones) as potent inhibitors of human protein kinase CK2","volume":"102","author":"Protopopov","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0155","doi-asserted-by":"crossref","DOI":"10.17305\/bjbms.2020.5036","article-title":"The role of glycogen synthase kinase 3 (GSK3) in Cancer with emphasis on ovarian Cancer development and progression: a comprehensive review","author":"Glibo","year":"2020","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.bmc.2025.118375_bb0160","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1080\/09168451.2020.1789445","article-title":"A novel GSK3 inhibitor that promotes self-renewal in mouse embryonic stem cells","volume":"84","author":"Kobayashi","year":"2020","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.bmc.2025.118375_bb0165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt Signalling pathway and Cancer","volume":"30","author":"Vara","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bmc.2025.118375_bb0170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/bab.1896","article-title":"FCX-146, a potent allosteric inhibitor of Akt kinase in Cancer cells: Lead optimization of the second-generation Arylidene Indanone scaffold","volume":"68","author":"Balasubramaniam","year":"2020","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.bmc.2025.118375_bb0175","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3389\/fonc.2019.01377","article-title":"Aberrant RON and MET co-overexpression as novel prognostic biomarkers of shortened patient survival and therapeutic targets of tyrosine kinase inhibitors in pancreatic Cancer","volume":"9","author":"Hu","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmc.2025.118375_bb0180","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3390\/ph16111597","article-title":"Repurposing synthetic congeners of a natural product Aurone unveils a Lead antitumor agent inhibiting folded P-loop conformation of MET receptor tyrosine kinase","volume":"16","author":"Hassan","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmc.2025.118375_bb0185","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tranon.2016.10.003","article-title":"PLK1, a potential target for Cancer therapy","volume":"10","author":"Liu","year":"2017","journal-title":"Transl Oncol"},{"key":"10.1016\/j.bmc.2025.118375_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139870","article-title":"Green synthesis and anticancer evaluation of Dispiroheterocycles containing Isatin, Tetrahydrobetacarboline, Pyrrolidine and Aurone motifs","volume":"1321","author":"Mohan","year":"2025","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2025.118375_bb0195","first-page":"13","article-title":"New insights into the characteristics of DRAK2 and its role in apoptosis: from molecular mechanisms to clinically applied potential","author":"Zheng","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2025.118375_bb0200","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.leukres.2013.01.012","article-title":"The MYB oncogene can suppress apoptosis in acute myeloid leukemia cells by transcriptional repression of DRAK2 expression","volume":"37","author":"Ye","year":"2013","journal-title":"Leuk Res"},{"key":"10.1016\/j.bmc.2025.118375_bb0205","first-page":"21","article-title":"DAP kinase-related apoptosis-inducing protein kinase 2 (DRAK2) is a key regulator and molecular marker in chronic lymphocytic leukemia","author":"Szoltysek","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2025.118375_bb0210","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.bmcl.2016.03.111","article-title":"Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening","volume":"26","author":"Jung","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118375_bb0215","first-page":"269","article-title":"Traditional uses, phytochemistry, pharmacology, and toxicology of Coreopsis tinctoria Nutt.: a review","author":"Shen","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.bmc.2025.118375_bb0220","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10531-016-1246-z","article-title":"Historical introduction, geographical distribution, and biological characteristics of alien plants in China","volume":"26","author":"Chen","year":"2016","journal-title":"Biodivers Conserv"},{"key":"10.1016\/j.bmc.2025.118375_bb0225","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10600-022-03782-y","article-title":"Chemical constituents of Coreopsis tinctoria","volume":"58","author":"Abdurehman","year":"2022","journal-title":"Chem Nat Compd"},{"key":"10.1016\/j.bmc.2025.118375_bb0230","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3987\/COM-21-14481","article-title":"Synthesis, characterization, and DRAK2 inhibitory activities of hydroxyaurone derivatives","volume":"102","author":"Zhao","year":"2021","journal-title":"Heterocycles"},{"key":"10.1016\/j.bmc.2025.118375_bb0235","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1134\/S1070363223010206","article-title":"Synthesis and anti-hepatocarcinoma effects of peracetyl glycosyl aurone derivatives","volume":"93","author":"Li","year":"2023","journal-title":"Russ J Gen Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0240","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.2174\/1568026616666160216160112","article-title":"Are human tyrosinase and related proteins suitable targets for melanoma therapy?","volume":"16","author":"Buitrago","year":"2016","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0245","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1021\/jm050715i","article-title":"Discovery of benzylidenebenzofuran-3(2H)-one (aurones) as inhibitors of tyrosinase derived from human melanocytes","volume":"49","author":"Okombi","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0250","doi-asserted-by":"crossref","first-page":"8307","DOI":"10.1080\/07391102.2022.2132296","article-title":"Synthesis and vitro, kinetic, QSAR, docking and drug-likeness studies","volume":"41","author":"Alshaye","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2025.118375_bb0255","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/cbic.201402003","article-title":"Investigation of binding-site homology between mushroom and bacterial tyrosinases by using aurones as effectors","volume":"15","author":"Haudecoeur","year":"2014","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bmc.2025.118375_bb0260","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/acsmedchemlett.6b00369","article-title":"2-Hydroxypyridine-N-oxide-embedded aurones as potent human tyrosinase inhibitors","volume":"8","author":"Haudecoeur","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118375_bb0265","first-page":"246","article-title":"Resorcinol-based hemiindigoid derivatives as human tyrosinase inhibitors and melanogenesis suppressors in human melanoma cells","author":"Roulier","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0270","first-page":"266","article-title":"Design and synthesis of 4-amino-2\u2032,4\u2032-dihydroxyindanone derivatives as potent inhibitors of tyrosinase and melanin biosynthesis in human melanoma cells","author":"Lazinski","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0275","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canlet.2019.02.035","article-title":"Cathepsin B: a sellsword of cancer progression","volume":"449","author":"Mijanovic","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmc.2025.118375_bb0280","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/14728222.2013.740461","article-title":"Cathepsin B as a cancer target","volume":"17","author":"Gondi","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bmc.2025.118375_bb0285","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrc4027","article-title":"Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response","volume":"15","author":"Olson","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2025.118375_bb0290","first-page":"31","article-title":"Synthesis of propynyloxy substituted novel aurones as potent cathepsin B inhibitors","author":"Saroha","year":"2021","journal-title":"Chem Data Collect"},{"key":"10.1016\/j.bmc.2025.118375_bb0295","first-page":"5","article-title":"Ultrasound assisted one-pot multicomponent greener synthesis of 1,2,3-triazole incorporated aurone hybrids: cathepsin B inhibition, anti-cancer activity against AGS cell line, and in-silico docking evaluation","author":"Saroha","year":"2022","journal-title":"Curr Res Green Sustain Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0300","first-page":"5","article-title":"Novel 1,2,3-triazole-aurone hybrids as cathepsin B inhibitors: one-pot synthesis, anti-proliferative, and drug modeling studies","author":"Saroha","year":"2022","journal-title":"Eur J Med Chem Rep"},{"key":"10.1016\/j.bmc.2025.118375_bb0305","first-page":"140","article-title":"Morpholine tethered aurones: design, synthesis, biological, kinetic and molecular docking studies","author":"Saroha","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0310","first-page":"1013","article-title":"Differential immunohistochemical localization of xanthine oxidase in normal and neoplastic human breast epithelium","volume":"11","author":"Cook","year":"1997","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bmc.2025.118375_bb0315","first-page":"10","article-title":"Xanthine oxidase\/dehydrogenase activity as a source of oxidative stress in prostate cancer tissue","author":"Veljkovi\u0107","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.bmc.2025.118375_bb0320","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00204-024-03696-4","article-title":"Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants","volume":"98","author":"Jomova","year":"2024","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.bmc.2025.118375_bb0325","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1039\/D2RA06997K","article-title":"Unveiling the inhibitory mechanism of aureusidin targeting xanthine oxidase by multi-spectroscopic methods and molecular simulations","volume":"13","author":"He","year":"2023","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2025.118375_bb0330","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.21037\/tcr-23-1190","article-title":"Do alkaline phosphatases have great potential in the diagnosis, prognosis, and treatment of tumors?","volume":"12","author":"Jiang","year":"2023","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.bmc.2025.118375_bb0335","doi-asserted-by":"crossref","first-page":"35077","DOI":"10.1039\/D1RA07379F","article-title":"2-Benzylidenebenzofuran-3(2H)-ones as a new class of alkaline phosphatase inhibitors: synthesis, SAR analysis, enzyme inhibitory kinetics and computational studies","volume":"11","author":"Ashraf","year":"2021","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2025.118375_bb0340","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/bmb.2006.49403402066","article-title":"Cytochrome P450 enzymes in drug metabolism and chemical toxicology: an introduction","volume":"34","author":"Furge","year":"2006","journal-title":"Biochem Mol Biol Educ"},{"key":"10.1016\/j.bmc.2025.118375_bb0345","first-page":"173","article-title":"Human cytochrome P4501A2","volume":"148","author":"Landi","year":"1999","journal-title":"IARC Sci Publ"},{"key":"10.1016\/j.bmc.2025.118375_bb0350","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/bdd.2259","article-title":"Selective inhibitory effects of HYIpro-3-1 on CYP1A2 in human liver microsomes","volume":"42","author":"Kim","year":"2021","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.bmc.2025.118375_bb0355","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1158\/1078-0432.CCR-11-0043","article-title":"Exploring breast Cancer estrogen disposition: the basis for endocrine manipulation","volume":"17","author":"L\u00f8nning","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2025.118375_bb0360","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11418-022-01678-3","article-title":"Aromatase inhibitors isolated from a flowering tea, snow Chrysanthemum (the Capitula of Coreopsis tinctoria Nutt.)","volume":"77","author":"Luo","year":"2023","journal-title":"J Nat Med"},{"key":"10.1016\/j.bmc.2025.118375_bb0365","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00001813-200202000-00003","article-title":"COX-2 inhibitors in Cancer treatment and prevention, a recent development","volume":"13","author":"Xu","year":"2002","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.bmc.2025.118375_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115960","article-title":"Design, synthesis and biological evaluation of novel Indanone containing Spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents","volume":"32","author":"Abolhasani","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0375","first-page":"1259","article-title":"Microtubules destabilizing agents binding sites in tubulin","author":"Alp\u00edzar-Pedraza","year":"2022","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2025.118375_bb0380","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2014.09.051","article-title":"Recent developments in tubulin polymerization inhibitors: an overview","volume":"87","author":"Kaur","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0385","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/cbdd.12805","article-title":"Anticancer activity of gallic acid template-based benzylidene indanone derivative as microtubule destabilizer","volume":"88","author":"Singh","year":"2016","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2025.118375_bb0390","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10822-018-0109-y","article-title":"Insight into microtubule destabilization mechanism of 3,4,5-trimethoxyphenyl indanone derivatives using molecular dynamics simulation and conformational modes analysis","volume":"32","author":"Tripathi","year":"2018","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bmc.2025.118375_bb0395","first-page":"9","article-title":"Semisynthetic aurones inhibit tubulin polymerization at the colchicine-binding site and repress PC-3 tumor xenografts in nude mice and myc-induced T-ALL in zebrafish","author":"Xie","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2025.118375_bb0400","first-page":"17","article-title":"Semisynthetic aurones A14 protects against T-cell acute lymphoblastic leukemia via suppressing proliferation and inducing cell cycle arrest with apoptosis","author":"Wang","year":"2022","journal-title":"Chin Med"},{"key":"10.1016\/j.bmc.2025.118375_bb0405","first-page":"1321","article-title":"Novel indeno-pyrazole and indeno-pyrimidine conjugates: synthesis, DFT, anticancer screening and in silico studies as potent tubulin inhibitors","author":"Elnaggar","year":"2025","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2025.118375_bb0410","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/BCJ20160583","article-title":"Topoisomerases as anticancer targets","volume":"475","author":"Delgado","year":"2018","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2025.118375_bb0415","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-biochem-061809-100002","article-title":"New mechanistic and functional insights into DNA topoisomerases","volume":"82","author":"Chen","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bmc.2025.118375_bb0420","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1021\/acsmedchemlett.6b00242","article-title":"Scaffold-hopping of aurones: 2-arylideneimidazo[1,2-a]pyridinones as topoisomerase II\u03b1-inhibiting anticancer agents","volume":"7","author":"Priyadarshani","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118375_bb0425","first-page":"67","article-title":"Organocatalyzed umpolung addition for synthesis of heterocyclic-fused arylidene-imidazolones as anticancer agents","author":"Kumar","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0430","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrm.2017.53","article-title":"The multifaceted roles of PARP1 in DNA repair and chromatin remodelling","volume":"18","author":"Chaudhuri","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bmc.2025.118375_bb0435","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1021\/jm5002502","article-title":"Discovery and structure-activity relationship of novel 2,3-dihydrobenzofuran-7-carboxamide and 2,3-dihydrobenzofuran-3(2H)-one-7-carboxamide derivatives as poly(ADP-ribose)polymerase-1 inhibitors","volume":"57","author":"Patel","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0440","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1021\/acs.jmedchem.8b01709","article-title":"Design and synthesis of poly(ADP-ribose) polymerase inhibitors: impact of adenosine pocket-binding motif appendage to the 3-oxo-2,3-dihydrobenzofuran-7-carboxamide on potency and selectivity","volume":"62","author":"Velagapudi","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0445","first-page":"34","article-title":"Systematic inhibitor selectivity between PARP1 and PARP2 enzymes: molecular implications for ovarian cancer personalized therapy","author":"Zuo","year":"2021","journal-title":"J Mol Recognit"},{"key":"10.1016\/j.bmc.2025.118375_bb0450","first-page":"2","article-title":"Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?","author":"Borst","year":"2012","journal-title":"Open Biol"},{"key":"10.1016\/j.bmc.2025.118375_bb0455","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2025.118375_bb0460","first-page":"25","article-title":"Synthesis and anticancer cytotoxicity of azaaurones overcoming multidrug resistance","author":"Toth","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118375_bb0465","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ejmech.2016.06.039","article-title":"2-Indolylmethylenebenzofuranones as first effective inhibitors of ABCC2","volume":"122","author":"Baiceanu","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0470","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.4155\/fmc-2017-0308","article-title":"Ovarian cancer cells cisplatin sensitization agents selected by mass cytometry target ABCC2 inhibition","volume":"10","author":"Comsa","year":"2018","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0475","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1083\/jcb.200907014","article-title":"Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes","volume":"186","author":"Simonsen","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bmc.2025.118375_bb0480","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1038\/onc.2017.295","article-title":"VPS34 stimulation of p62 phosphorylation for Cancer progression","volume":"36","author":"Jiang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2025.118375_bb0485","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.apsb.2019.01.016","article-title":"Aurone derivatives as Vps34 inhibitors that modulate autophagy","volume":"9","author":"Li","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2025.118375_bb0490","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3747\/co.v15i5.371","article-title":"Histone deacetylase inhibitors as novel anticancer therapeutics","volume":"15","author":"Walkinshaw","year":"2008","journal-title":"Curr Oncol"},{"key":"10.1016\/j.bmc.2025.118375_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116846","article-title":"Hemithioindigo-based histone deacetylase inhibitors induce a light-dependent anticancer effect","volume":"279","author":"Josa-Culler\u00e9","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117300","article-title":"Dual targeted 2-Benzylideneindanone pendant Hydroxamic acid group exhibits selective HDAC6 inhibition along with tubulin stabilization effect","volume":"86","author":"Kumar","year":"2023","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118375_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2005.12.009","article-title":"Free radicals, metals and antioxidants in oxidative stress-induced cancer","volume":"160","author":"Valko","year":"2006","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmc.2025.118375_bb0510","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.bmc.2025.118375_bb0515","first-page":"26","article-title":"Aurones and flavonols from Coreopsis lanceolata L. flowers and their anti-oxidant, pro-inflammatory inhibition effects, and recovery effects on alloxan-induced pancreatic islets in zebrafish","author":"Kim","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118375_bb0520","doi-asserted-by":"crossref","first-page":"9647","DOI":"10.1039\/D0NJ00758G","article-title":"Bisaurones \u2013 enzymatic production and biological evaluation","volume":"44","author":"Novakovic","year":"2020","journal-title":"New J Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625003165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625003165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:58:27Z","timestamp":1758589107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625003165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":104,"alternative-id":["S0968089625003165"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118375","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aurone and its analogues as targeted drugs for the anticancer treatment","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118375"}}